By months 23, most patients are at a meaningful dose and seeing consistent appetite reduction and early weight loss
The best available evidence suggests retatrutide can produce major fat-mass reduction and that lean-mass loss, relative to total weight loss, appears similar to other obesity therapies rather than disproportionately worse
People choose to microdose Wegovy for a variety of reasons, from reducing the cost of treatment to maintaining their weight long-term to limiting side effects
GLP-1 medicines such as semaglutide and tirzepatide are prescription treatments that must be prescribed and supervised by a qualified doctor
patients, however, wont see those savings until 2032 at the earliest, unless they access medications through Canadian pharmacy services
Pairing it with vitamin C and sun protection gives it the best supporting environment